Q3T0Y5 (PSA2_BOVIN) Bos taurus (Bovine)

Proteasome subunit alpha type-2 UniProtKBInterProSTRINGInteractive Modelling

234 aa; Sequence (Fasta) 64 identical sequences

Sequence Features

 6-28Proteasome alpha-subunit, N-terminal domain
IPR000426PF10584
 31-212Proteasome, subunit alpha/beta
IPR001353PF00227

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
The human 26S Proteasome at 6.8 Ang. Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
5ln31-234
Human Constitutive 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4r3o2-234
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
30×MG;1iru2-234
Human constitutive 20S proteasome in complex with carfilzomib Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
3BV;4r672-234
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;5t0g2-234
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;5t0i2-234
The human 26S proteasome at 3.9 A Heteromer
O14818; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436;
MG;ADP;ATP;5l4g2-234
Structure of the human 26S proteasome bound to USP14-UbAl Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ADP;5gjq2-234
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
5vfo3-234
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfp3-234
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfq3-234
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfr3-234
'Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfs3-234
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;5vft3-234
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;5vfu3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msb3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msd3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6mse3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
MG;ZN;ATP;ADP;6msg3-234
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;5t0h3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;ATP;6msh3-234
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;5t0j3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msj3-234
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msk3-234
Native human 20S proteasome at 1.8 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG; 57×CL;5le54-233
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG; 58×CL;5ley4-233
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6V7;K;1PE; 10×MG; 52×CL;5lf44-233
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6V8;K;1PE; 10×MG; 51×CL;5lf74-233
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE;6VC; 10×MG; 56×CL;5lf14-233
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
PHQ;K;1PE; 10×MG; 55×CL;5lf64-233
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG;BO2; 51×CL;5lf34-233
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;ACT; 10×MG;1PE;5lez4-233
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;MG;1PE;5lex4-233
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG; 58×CL;5lf04-233
Endogeneous native human 20S proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6r704-233
'Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selective... Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
BZ7;6avo4-233
Human 26S proteasome in complex with Oprozomib Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6;
ADP;5m324-233
Human Immunoproteasome 20S particle in complex with compound 1 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
12×NA;SCN;HUJ;6e5b5-233
Human 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6rgq4-232
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
KNM;5a0q6-227
Human 20S-PA200 Proteasome Complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
I6P;K0W;6rey19-232